These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1710410)

  • 61. Steroid-responsive type II anti-factor VIII:C autoantibody in a nonhemophiliac child.
    Carter CJ; Devine DV; Rogers PC; Wadsworth LD
    Am J Pediatr Hematol Oncol; 1990; 12(2):205-9. PubMed ID: 2116097
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Acquired factor VIII inhibitor in a patient with adenocarcinoma of the lung.
    Kondo H; Shigekiyo T; Kojima A; Saito S; Saijo N
    Jpn J Clin Oncol; 1992 Feb; 22(1):49-53. PubMed ID: 1573789
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.
    Andersson LO; Forsman N; Huang K; Larsen K; Lundin A; Pavlu B; Sandberg H; Sewerin K; Smart J
    Proc Natl Acad Sci U S A; 1986 May; 83(9):2979-83. PubMed ID: 3085106
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Preferential use of lambda L chain in lamin B autoantibodies.
    Reeves WH; Ali SA
    J Immunol; 1989 Dec; 143(11):3614-8. PubMed ID: 2511246
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy.
    Stricker RB; Barlogie B; Kiprov DD
    J Rheumatol; 1994 Feb; 21(2):350-2. PubMed ID: 8182649
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
    Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
    Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Isotypy of serum monoclonal immunoglobulins in human immunodeficiency virus-infected adults.
    Briault S; Courtois-Capella M; Duarte F; Aucouturier P; Preud'Homme JL
    Clin Exp Immunol; 1988 Nov; 74(2):182-4. PubMed ID: 3147151
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Heterogeneity of human circulating anticoagulants against antihemophilic factor (factor VIII).
    Poon MC; Wine AC; Ratnoff OD; Bernier GM
    Blood; 1975 Sep; 46(3):409-16. PubMed ID: 50101
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Treatment of factor VIII inhibitors.
    Kasper CK
    Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380
    [No Abstract]   [Full Text] [Related]  

  • 70. Acquired factor VIII inhibitor in a patient with multiple sclerosis treated with interferon β-1a.
    Pandya D; Hellerslia V; Gettings E
    J Neuroimmunol; 2020 Mar; 340():577146. PubMed ID: 31945592
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunochemical characterization of a polyclonal human antibody to factor IX.
    Reisner HM; Roberts HR; Krumholz S; Yount WJ
    Blood; 1977 Jul; 50(1):11-9. PubMed ID: 405991
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations.
    Ortel TL; Moore KD; Quinn-Allen MA; Okamura T; Sinclair AJ; Lazarchick J; Govindan R; Carmagnol F; Kane WH
    Blood; 1998 Jun; 91(11):4188-96. PubMed ID: 9596666
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Life-threatening haemorrhage in a patient with rheumatoid arthritis and a lupus anticoagulant coexisting with acquired autoantibodies against factor VIII.
    Ballard HS; Nyamuswa G
    Br J Rheumatol; 1993 Jun; 32(6):515-7. PubMed ID: 8508289
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis.
    Coller BS; Hultin MB; Hoyer LW; Miller F; Dobbs JV; Dosik MH; Berger ER
    Blood; 1981 Sep; 58(3):619-24. PubMed ID: 6789845
    [TBL] [Abstract][Full Text] [Related]  

  • 75. An unusual cause of bruising in an 80-year-old woman.
    Kelly J; Gattens M; Geraghty R
    Age Ageing; 2000 May; 29(3):261-3. PubMed ID: 10855910
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An acquired inhibitor to factor VIIIC in a non-hemophiliac: twenty years of observation and characterization.
    Coots MC; Glueck HI
    Am J Hematol; 1987 Apr; 24(4):415-24. PubMed ID: 3105306
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Acquired factor VIII inhibitor with squamous cell cancer of the epiglottis.
    Shastri KA; Logue GL; Zeid MY; Behrens AN; Lenahan EJ; Haar JG
    Arch Otolaryngol Head Neck Surg; 1990 Mar; 116(3):350-3. PubMed ID: 2106329
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A case of factor 8 inhibitor developed after electric-shock therapy.
    Ollendorff P; Amris CJ
    Scand J Haematol; 1967 Dec; 4(6):401-10. PubMed ID: 6082222
    [No Abstract]   [Full Text] [Related]  

  • 79. Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody.
    Berger JR; Rosenfeld WE; Sheremata WA; Lian EC; Ayyar DR; Melo J; Kloss K
    Neurology; 1983 Sep; 33(9):1224-6. PubMed ID: 6412159
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Presentation of an acquired factor VIII inhibitor with a muscular haematoma mimicking a deep venous thrombosis in a patient with breast cancer.
    López R; Mateo J; Cruz J; López A; Urrutia T; Fontcuberta J
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):680-2. PubMed ID: 8562841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.